Domov › Kolorektálny karcinóm › Kansas

Klinické štúdie Kolorektálny karcinóm v štáte Kansas

19 štúdií pre Kolorektálny karcinóm hľadá účastníkov v zariadeniach v štáte Kansas.

Mestá v štáte Kansas

Oficiálny text štúdie (anglicky)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Central Care Cancer Center - Garden City, Garden City
Central Care Cancer Center - Great Bend, Great Bend
Veteran Administration Eastern Kansas Healthcare, Leavenworth
a 4 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

Family Communications After Genetic Testing

Central Care Cancer Center - Garden City, Garden City
Central Care Cancer Center - Great Bend, Great Bend
Mercy Hospital Pittsburg, Pittsburg
a 1 ďalších

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07143487

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

University of Kansas Clinical Research Center, Fairway
University of Kansas Cancer Center, Kansas City
University of Kansas Hospital-Westwood Cancer Center, Westwood

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT05803382

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Westwood

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06218914

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Cancer Center of Kansas, Wichita

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Cancer Center of Kansas, Wichita

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06662786

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

University of Kansas, Fairway

Prebieha náborFáza 1

Vek 12 až 120 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT04222413

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

The University of Kansas Clinical Research Center, Westwood

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06445062

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

University of Kansas Clinical Research Center, Fairway
University of Kansas Cancer Center, Kansas City
University of Kansas Hospital-Indian Creek Campus, Overland Park
a 1 ďalších

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06696768

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Clinical Study Site, Westwood

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT07228832

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

The University of Kansas Cancer Center, Kansas City

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT05592626

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

University of Kansas Clinical Research Center, Fairway
University of Kansas Cancer Center, Kansas City
University of Kansas Cancer Center-Overland Park, Overland Park
a 2 ďalších

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 7. 2026 · NCT05691491

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Cancer Centers of Kansas, Wichita

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 7. 2026 · NCT06937177

Lead-212 PSV359 Therapy for Patients With Solid Tumors

University of Kansas, Kansas City

Prebieha náborFáza 1/2

Vek 18 až 90 · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT06710756

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

The University of Kansas Clinical Research Center, Fairway

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 6. 2026 · NCT06607458

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Central Care Cancer Center - Garden City, Garden City
Central Care Cancer Center - Great Bend, Great Bend
Mercy Hospital Pittsburg, Pittsburg

Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 3. 2026 · NCT07018869

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

The University of Kansas Cancer Center, Fairway

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 3. 2026 · NCT06244771

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

HaysMed, Hays
Lawrence Memorial Hospital, Lawrence
The University of Kansas Cancer Center - Olathe, Olathe
a 6 ďalších

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 3. 2026 · NCT06418204

A Study of IBI363 in Subjects with Advanced Solid Malignancies

University of Kansas Medical Center (KUMC), Fairway

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 12. 2024 · NCT06281678

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.